Clinical Trial Update: ToleroMune Grass Exposure Unit Study [Phase 2]

View source ↗

Summary

A Phase 2 study of ToleroMune for grass pollen allergy and allergic rhinoconjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis
• Grass Pollen Allergy

Drugs mentioned

• ToleroMune

Snippet

Sponsor: Circassia Limited | Conditions: Grass Allergy, Rhinoconjunctivitis | Phase 2 | Status: COMPLETED